Immunoprecise Antibodies Ltd expected to post a loss of 17 cents a share - Earnings Preview

Mindwalk Holdings

05/07/2023 13:35

* Immunoprecise Antibodies Ltd  IPA.OQ   IPA.O  is expected
to show a rise in quarterly revenue when it reports  results on
July 7. 
    * The Victoria British Columbia-based  company is expected
to
report  a 8.9% increase in revenue to C$5.706 million from
C$5.24 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Immunoprecise
Antibodies
Ltd is for a loss of 17 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Immunoprecise
Antibodies Ltd is $8​, above​ its last closing price of $3.04.
​​​

This summary was machine generated July 5 at 12:35 GMT.  All
figures in Canadian dollars  unless otherwise stated